SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is trending as investors capitalize on massive growth in the protocol's perpetual derivatives exchange volume and anticipation surrounding upcoming institutional integrations. Community sentiment remains highly bullish, with many traders drawing parallels to the early stages of major crypto assets while focusing on the token's role as foundational infrastructure for on-chain finance.

Spacecoin is a satellite-based decentralized internet network that aims to provide reliable, permissionless connectivity across the globe. It is building a constellation of blockchain-enabled small satellites in low-Earth orbit to transmit data back to the Earth without heavily relying on traditional internet infrastructure such as cell towers and fiber-optic cables. The goal is to provide a reliable lifeline connection for the 2.6 billion people globally who have never connected to the Internet and an additional 3.5 billion who live with restricted access.  Spacecoin plans to offer services in its target countries of Nigeria, Indonesia, and India for as low as $1-2 per month per user. The network works as an open system where anyone can add satellites. The first satellite launched in December 2024, with three more planned for October 2025.

Spacelens

Community enthusiasm is surging around $SPACE.X as investors track anticipation for a potential high-profile IPO and the growing integration of blockchain technology within the space and DePIN sectors. Discussions highlight the project's strategic positioning alongside aerospace infrastructure partners and broader market interest in decentralized satellite networks.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll (TROLL) is generating significant momentum as the community spotlights its status as an original meme coin with established IP rights, recently bolstered by its listing on Coinbase and active accumulation by notable market participants. Investors are drawing parallels to previous breakout meme cycles, with many actively discussing the potential for a long-term run as they rally around its recognizable cultural footprint.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is trending as investors debate the stock's turnaround potential following its recent volatility, with many community members discussing the impact of BetterHelp's transition to insurance-based revenue and the firm's overall valuation. Sentiment is heavily divided between those highlighting the company's long-term leadership in virtual care and those frustrated by the stock's multi-year downward pressure and perceived management shortcomings.

NEOS ETF Trust - NEOS S&P 500 High Income ETF

NEOS S&P 500 High Income ETF

The NEOS S&P 500 High Income ETF (SPYI) is trending as investors favor its monthly cash flow and tax-efficient distribution strategy, which leverages index options to generate yield while maintaining exposure to the S&P 500. Community discussion frequently highlights the fund's role as a staple for income-focused portfolios, with active debate regarding its stability compared to traditional growth indices and other high-yield alternatives like QQQI.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending due to the Depository Trust & Clearing Corporation (DTCC) announcing plans to integrate its tokenization platform with the Stellar network, signaling major institutional adoption for real-world assets. Community members are actively debating the token's long-term utility versus speculative hype, with many bullishly comparing its potential to pass other major cryptocurrencies while skeptics warn of potential pullbacks and market volatility.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is drawing significant community attention as investors weigh its potential for enterprise utility against ongoing concerns regarding token dilution and price performance. While some remain bullish on its long-term infrastructure and institutional partnerships, others are actively debating its viability compared to other assets in the sector.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is currently a focal point for investors due to intensifying discussions around a potential short squeeze, fueled by high short interest and anticipation of major government contract announcements. Community sentiment is deeply polarized between long-term believers citing institutional accumulation and bears who remain skeptical of the company's path to profitability and recent executive selling.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is attracting significant community attention as traders actively discuss its potential for a sustained breakout alongside broader memecoin sector trends. Investors are debating price support levels and long-term price targets while looking for signals from the wider crypto market to fuel the next leg of upward momentum.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as CEO Jamie Dimon faces significant community backlash and internal scrutiny over controversial corporate conduct, while the firm simultaneously navigates high-stakes negotiations regarding its role in major upcoming tech IPOs and potential multi-billion dollar acquisition strategies. Market participants are actively debating the bank's aggressive stance against crypto legislation, ongoing executive controversies, and its role as a power broker in the AI infrastructure financing boom.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acumen Pharmaceuticals (ABOS) Expected to Announce Quarterly Earnings on Tuesday

Acumen Pharmaceuticals (NASDAQ:ABOS) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-acumen-pharmaceuticals-inc-stock...

Short Interest in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Increases By 46.4%

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totaling 1,545,029 shares, an increase of 46.4% from the March 31st total of 1,055,415 shares. Approximately 2.4% of the...

Acumen Pharmaceuticals (NASDAQ:ABOS) Trading 0.7% Higher   - Still a Buy?

Acumen Pharmaceuticals (NASDAQ:ABOS) Shares Up 0.7% - Here's Why...

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Acumen Pharmaceuticals (ABOS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and ADC Therapeutics SA (ADCT) have performed compared to their sector so far this year.

Acumen Pharmaceuticals (NASDAQ:ABOS) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Acumen Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Sunday...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) has been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the stock, Marketbeat Ratings...

Acumen Pharmaceuticals (NASDAQ:ABOS) Receives "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and issued a $8.00 target price on shares of Acumen Pharmaceuticals in a report on Thursday...

Acumen Pharmaceuticals Q4 Earnings Call Highlights

Acumen Pharmaceuticals (NASDAQ:ABOS) outlined progress across its lead Alzheimer's disease program and an emerging "enhanced brain delivery" (EBD) platform during its fourth-quarter and full-year 2025 update, while management reiterated expectations for a key Phase 2 readout later in 2026 and provid...

Acumen Pharmaceuticals (NASDAQ:ABOS) Announces Earnings Results, Beats Expectations By $0.09 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS - Get Free Report) released its earnings results on Thursday. The company reported ($0.41) earnings per share for the quarter, topping analysts' consensus estimates of ($0.50) by $0.09...

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.35	--	--	N/A
Q1 '26	-$0.40	-$0.33	18.07%	BEAT
Q4 '25	-$0.46	-$0.40	12.98%	BEAT
Q3 '25	-$0.60	-$0.44	27.03%	BEAT
Q2 '25	-$0.49	-$0.68	-39.17%	MISSED

ABOS
Acumen Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest ABOS News

ABOSAcumen Pharmaceuticals Inc